Support

Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Targeting the right antigens in the right patients

Oct 12, 2020 Am. J. Trop. Med. Hyg

Whole Genome Sequencing of Dengue Virus Serotype 2 from Two Clinical Isolates and AU3 AU2 Serological Profile of Dengue in the 2015–2016 Nepal Outbreak

Manandhar K, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen A, Ngono AE, Zompi S, Sessions O, Shresta S.

Sep 21, 2020 J Immunol

TL1A Promotes Lung Tissue Fibrosis and Airway Remodeling

Herro R, Miki H, Sethi GS, Mills D, Mehta AK, Nguyen XX, Feghali-Bostwick C, Miller M, Broide DH, Soloff R, Croft M

May 19, 2020 J Transl Med

The Urgent Need for Integrated Science to Fight COVID-19 Pandemic and Beyond

Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA Jr, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, Ogino S, Seymour JF, Abraham A, Cauda V, Gupta S, Ramakrishna S, Sellke FW, Sorooshian A, Wallace Hayes A, Martinez-Urbistondo M, Gupta M, Azadbakht L, Esmaillzadeh A, Kelishadi R, Esteghamati A, Emam-Djomeh Z, Majdzadeh R, Palit P, Badali H, Rao I, Saboury AA, Jagan Mohan Rao L, Ahmadieh H, Montazeri A, Fadini GP, Pauly D, Thomas S, Moosavi-Movahed AA, Aghamohammadi A, Behmanesh M, Rahimi-Movaghar V, Ghavami S, Mehran R, Uddin LQ, Von Herrath M, Mobasher B, Rezaei N.